|
MYH10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63091762317435E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76636483217862E-13 |
| Normal-vs-Stage2 |
8.84530004796602E-10 |
| Normal-vs-Stage3 |
6.87000001331484E-09 |
| Normal-vs-Stage4 |
4.61129999740351E-08 |
| Stage1-vs-Stage2 |
6.625800E-01 |
| Stage1-vs-Stage3 |
6.478000E-01 |
| Stage1-vs-Stage4 |
4.060000E-01 |
| Stage2-vs-Stage3 |
3.815000E-01 |
| Stage2-vs-Stage4 |
5.678000E-01 |
| Stage3-vs-Stage4 |
2.119400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.33260000204183E-09 |
| Normal-vs-Asian |
2.28489999998249E-06 |
| Caucasian-vs-AfricanAmerican |
6.361200E-01 |
| Caucasian-vs-Asian |
5.121800E-01 |
| AfricanAmerican-vs-Asian |
5.594000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
2.6810999997906E-07 |
| Male-vs-Female |
2.341100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.02320000250344E-08 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.75329972762484E-10 |
| Normal-vs-Extreme_Obese |
2.14169999999125E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.124800E-01 |
| Normal_Weight-vs-Obese |
3.848200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.094800E-01 |
| Extreme_Weight-vs-Obese |
3.926200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.917200E-01 |
| Obese-vs-Extreme_Obese |
8.952800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59312999999939E-05 |
| Normal-vs-Age(41-60Yrs) |
2.06139549874251E-11 |
| Normal-vs-Age(61-80Yrs) |
1.63136171238421E-12 |
| Normal-vs-Age(81-100Yrs) |
6.16410034126602E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.498200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.234400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.964100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.745600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.783200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
6.41149999758284E-09 |
| Normal-VS-KIRP CIMP |
3.915900E-03 |
| Normal-VS-Unclassified PRCC |
1.50800000264795E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.580000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.363600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.052200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.544400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.515000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.295600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.81170658872543E-13 |
| Normal-vs-N1 |
9.04269999990603E-08 |
| Normal-vs-N2 |
9.336800E-03 |
| N0-vs-N1 |
2.138600E-01 |
| N0-vs-N2 |
3.283600E-01 |
| N1-vs-N2 |
7.186000E-01 |
|
|
